A drug with the SMILES Cn1c(=O)c2c(ncn2CC(=O)N2CCN(S(=O)(=O)c3ccc(Cl)cc3)CC2)n(C)c1=O has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -2.150%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cn1c(=O)c2c(ncn2CC(=O)N2CCN(S(=O)(=O)c3ccc(Cl)cc3)CC2)n(C)c1=O
Cn1c(=O)c2c(ncn2CC(=O)N2CCN(S(=O)(=O)c3ccc(Cl)cc3)CC2)n(C)c1=O
7-[2-[4-(4-chlorophenyl)sulfonylpiperazin-1-yl]-2-oxoethyl]-1,3-dimethylpurine-2,6-dione